<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="370596">
  <stage>Registered</stage>
  <submitdate>28/04/2016</submitdate>
  <approvaldate>3/05/2016</approvaldate>
  <actrnumber>ACTRN12616000572460</actrnumber>
  <trial_identification>
    <studytitle>Appetite hormones in anorexia nervosa</studytitle>
    <scientifictitle>Appetite Regulatory Hormones in Adolescents Undergoing First Refeeding for Anorexia Nervosa</scientifictitle>
    <utrn />
    <trialacronym>ARHAN</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Anorexia nervosa</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Eating disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Nil interventions - all subjects will have routine clinical care. 
Mostly they are inpatients for the first 4 weeks and will have baseline, 1, 2 and 4 week bloods collected to measure appetite peptides. Then they attend outpatients at roughly monthly intervals until stable. We will collect blood samples to measure appetite peptides at the outpatient visits most closely approximating 8, 16 and 26 weeks and 12 months..
We will observe weight regain and maintenance over the study period. Weight will be measured each visit with scales to the nearest 0.1kg, height will be assessed by stadiometer at first visit.
</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in appetite peptides in relation to weight regain. The hormones will be assessed by ELISAs. Weight change will be assessed as above using digital scales recorded to the nearest 0.1kg.</outcome>
      <timepoint>Change from baseline to 12 months from initial refeeding.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in appetite hormones from baseline to other time points (i.e. not 12 months).
These will be assessed by serum assay.</outcome>
      <timepoint>2, 4, 8, 16 weeks, 6 months from initial refeeding admission</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>New admission for treatment of anorexia nervosa.
Age 14-20</inclusivecriteria>
    <inclusiveminage>14</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>20</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Age &lt;14 or age &gt;20.
Not first admission for treatment of anorexia (i.e. second or subsequent presentation).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>Paired testing comparing baseline to the time point. We estimate that 50 subjects tested at 12 months should be sufficient to have &gt;80% power to detect differences of clinically relevant magnitude at the p&lt;0.05 level. These would be &gt;10% change in absolute results. Because of the age and relatively high mobility of the participant population, it is likely that many subjects will not have 12 month samples collected, hence the larger number of intake subjects (i.e. up to 200).</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>16/05/2016</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>16/05/2018</anticipatedenddate>
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Westmead Hospital - Westmead</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Dept of Endocrinology and Diabetes, Westmead Hospital</primarysponsorname>
    <primarysponsoraddress>Department of Endocrinology and Diabetes,
Westmead Hospital.
Cnr Darcy and Hospital Roads,
Westmead. NSW. 2145</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Westmead Hospital</fundingname>
      <fundingaddress>Westmead Hospital.
Cnr Darcy and Hospital Roads,
Westmead. NSW. 2145</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress>None</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We hypothesise that people with anorexia requiring hospital admission for treatment will have abnormalities in appetite peptides, and that these may not return to normal even with weight restoration. A secondary hypothesis is that we may be able to identify a predictor of good outcome at 1 year.
This study will collect serial blood samples in people admitted to Westmead Hospital for treatment of anorexia nervosa.
Blood will be collected prior to refeeding and at the visits closest to 2, 4, 8, 16 weeks, 6 and 12 months.
</summary>
    <trialwebsite>None</trialwebsite>
    <publication>None</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes>None</publicnotes>
    <ethicscommitee>
      <ethicname>Western Sydney Local Health District</ethicname>
      <ethicaddress>Westmead Hospital,
Cnr Darcy and Hospital Roads,
Westmead. NSW. 2145</ethicaddress>
      <ethicapprovaldate>26/02/2016</ethicapprovaldate>
      <hrec>SSA/15/WMEAD/404</hrec>
      <ethicsubmitdate>1/10/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Jenny Gunton</name>
      <address>Room 2040, Level 2,
Westmead Hospital,
Cnr Darcy and Hospital Roads,
Westmead. NSW. 2145</address>
      <phone>+61 2 9845 8089</phone>
      <fax />
      <email>jenny.gunton@sydney.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jenny Gunton</name>
      <address>Room 2040, Level 2,
Westmead Hospital,
Cnr Darcy and Hospital Roads,
Westmead. NSW. 2145</address>
      <phone>+61298458089</phone>
      <fax />
      <email>jenny.gunton@sydney.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jenny Gunton</name>
      <address>Room 2040, Level 2,
Westmead Hospital,
Cnr Darcy and Hospital Roads,
Westmead. NSW. 2145</address>
      <phone>+61298458089</phone>
      <fax />
      <email>jenny.gunton@sydney.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jenny Gunton</name>
      <address>Room 2040, Level 2,
Westmead Hospital,
Cnr Darcy and Hospital Roads,
Westmead. NSW. 2145</address>
      <phone>+61298458089</phone>
      <fax />
      <email>jenny.gunton@sydney.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>